These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas. Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of gastric acid and gastrin secretion by somatostatin in man. Arnold R; Köbberling J; Creutzfeldt W Z Gastroenterol Verh; 1976; (10):43-50. PubMed ID: 64051 [TBL] [Abstract][Full Text] [Related]
7. [Effect of depot somatostatin on gastrin and stomach secretion in normal subjects and in patients with Zollinger-Ellison syndrome]. Raptis S; Dollinger HC; Escobar-Jimenez F; Pfeiffer EF Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():1006-9. PubMed ID: 1029163 [No Abstract] [Full Text] [Related]
8. Somatostatin: diabetes and acromegaly. Gerich JE Adv Intern Med; 1977; 22():251-72. PubMed ID: 190870 [No Abstract] [Full Text] [Related]
10. [The effects of somatostatin in acromegaly]. Schaison G; Roger M; Milhaud G Nouv Presse Med; 1976 Mar; 5(10):629-32. PubMed ID: 772591 [TBL] [Abstract][Full Text] [Related]
11. Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor. Wilson DM; Ceda GP; Bostwick DG; Webber RJ; Minkoff JR; Pont A; Hintz RL; Bensch KG; Kraemer FB; Rosenfeld RG J Clin Endocrinol Metab; 1984 Nov; 59(5):1002-5. PubMed ID: 6090497 [TBL] [Abstract][Full Text] [Related]
12. [Summary of work session 4: Effects of calcitonin and somatostatin on the stomach and pancreas--a possible therapeutic principle]. Goebell H; Hotz J Z Gastroenterol; 1976 Mar; 14 Suppl():221-8. PubMed ID: 822614 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion. Williams G; Anderson JV; Williams SJ; Bloom SR Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin and diabetes. Rizza RA; Gerich JE Med Clin North Am; 1978 Jul; 62(4):735-46. PubMed ID: 355738 [TBL] [Abstract][Full Text] [Related]
15. Somatostatin, basic and clinical studies. A review. Schally AV; Meyers CA Mater Med Pol; 1980; 12(1-2):28-32. PubMed ID: 6120265 [No Abstract] [Full Text] [Related]
16. Letter: Radioisotope scan--a possible aid in differentiating retained gastric antrum from Zollinger-Ellison syndrome in patients with recurrent peptic ulcer. Chaudhuri TK; Shirazi SS; Condon RE Gastroenterology; 1973 Oct; 65(4):697-8. PubMed ID: 4583568 [No Abstract] [Full Text] [Related]
17. Effects of somatostatin on gastric secretion and gastrin release in man. Raptis S; Dollinger HC; von Berger L; Schlegel W; Schröder KE; Pfeiffer EF Digestion; 1975; 13(1-2):15-26. PubMed ID: 1201817 [TBL] [Abstract][Full Text] [Related]
18. [Somatostatin -- a review (author's transl)]. Lucke C; Mitzkat HJ; von zur Mühlen A Klin Wochenschr; 1976 Apr; 54(7):293-301. PubMed ID: 1263405 [TBL] [Abstract][Full Text] [Related]
19. [Somatostatin]. Radbil' OS Klin Med (Mosk); 1978 May; 56(5):28-34. PubMed ID: 207926 [No Abstract] [Full Text] [Related]
20. Somatostatin: physiological and clinical significance. Guillemin R; Gerich JE Annu Rev Med; 1976; 27():379-88. PubMed ID: 779605 [No Abstract] [Full Text] [Related] [Next] [New Search]